Publications by authors named "B Bilgili"

Introduction: Diagnosing and treating lung cancer in early stages is essential for survival outcomes. The chest X-ray (CXR) remains the primary screening tool to identify lung cancers in the UK; however, there is a shortfall of radiologists, while demand continues to increase. Image analysis by machine-learning software has the potential to support radiology workflows with a focus on immediate triage of suspicious X-rays.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify risk factors influencing the mortality rates of patients with subarachnoid hemorrhage (SAH) by analyzing data from ICU follow-ups and treatment records over an eight-year period.
  • A total of 91 patients were analyzed, showing a mean age of 49.9 years, with complications including a significant link between higher APACHE II scores and increased mortality risk, particularly due to vasospasm.
  • Key findings suggested that longer periods on mechanical ventilation and the presence of vasospasm significantly increased mortality risk, highlighting the importance of early diagnosis and treatment for better patient outcomes.
View Article and Find Full Text PDF

Objective: This study aimed to define the predictors of critical illness development within 28 days postadmission during the first wave of the COVID-19 pandemic.

Materials And Methods: We conducted a prospective cohort study including 477 PCR-positive COVID-19 patients admitted to a tertiary care hospital in Istanbul from March 12 to May 12, 2020.

Results: The most common presenting symptoms were cough, dyspnea, and fatigue.

View Article and Find Full Text PDF

Background: The reliability of determining fluid responsiveness during surgery in geriatric patients is challenging. Our primary outcome was to determine the reliability of Corrected Flow Time (FTc) in predicting fluid responsiveness.

Methods: Elderly patients undergoing major surgery under general anesthesia were included.

View Article and Find Full Text PDF

Introduction: Favipiravir (FVP) is an antiviral and used to treat COVID-19. We aimed to document the safety and adverse events associated with FVP on the outcome of COVID-19 treatment.

Methodology: The study included 225 adult patients with moderate COVID-19 infection (World Health Organization scale-5).

View Article and Find Full Text PDF